| |
| |
|
| Insider
Information: |
Goeltz Ii Robert C. |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
267,614 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,389,613 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
267,614 |
|
|
| Total
Value |
$1,389,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 12.9%
|
 -104.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
Chief Financial Officer |
2017-05-12 |
32,756 |
2016-05-12 |
0 |
Premium* |
|
|
Unity Biotechnology Inc |
UBX |
Chief Financial Officer |
2020-06-22 |
161,027 |
2018-05-07 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Chief Financial Officer |
2024-01-23 |
73,831 |
2020-09-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-23 |
4/A |
A |
$0.00 |
$0 |
D/D |
22,000 |
73,831 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
21,300 |
73,131 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
AS |
$20.00 |
$40,080 |
D/D |
(2,004) |
51,831 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2023-12-19 |
4 |
D |
$18.09 |
$50,797 |
D/D |
(2,808) |
53,835 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2023-12-18 |
4 |
D |
$17.74 |
$48,767 |
D/D |
(2,749) |
56,643 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
AS |
$20.04 |
$81,142 |
D/D |
(4,049) |
59,392 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2023-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
63,441 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2022-12-16 |
4 |
S |
$30.66 |
$75,430 |
D/D |
(2,453) |
11,566 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
22,519 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2021-12-17 |
4 |
S |
$38.79 |
$25,061 |
D/D |
(621) |
7,019 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2021-12-16 |
4 |
S |
$39.59 |
$19,315 |
D/D |
(485) |
7,640 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
17,500 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Financial Officer |
• – – |
2020-09-09 |
4 |
B |
$21.57 |
$107,849 |
D/D |
5,000 |
5,000 |
2.74 |
% |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2020-06-22 |
4 |
D |
$9.67 |
$24,011 |
D/D |
(2,483) |
161,027 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2020-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
29,106 |
163,510 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2020-02-24 |
4 |
OE |
$3.43 |
$34,300 |
D/D |
10,000 |
134,404 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2019-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
21,075 |
124,404 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2018-10-10 |
4 |
OE |
$3.43 |
$17,150 |
D/D |
5,000 |
101,348 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Chief Financial Officer |
• – – |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,630 |
96,348 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-05-12 |
4 |
OE |
$4.47 |
$110,700 |
D/D |
19,967 |
32,756 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-04-10 |
4 |
OE |
$4.47 |
$13,418 |
D/D |
3,000 |
12,789 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-03-20 |
4 |
AS |
$19.60 |
$426,340 |
D/D |
(21,517) |
9,789 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-03-20 |
4 |
OE |
$4.47 |
$96,241 |
D/D |
21,517 |
31,306 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-03-09 |
4 |
OE |
$4.47 |
$11,182 |
D/D |
2,500 |
9,789 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2016-11-30 |
4 |
A |
$9.10 |
$11,723 |
D/D |
1,289 |
7,289 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
